Last reviewed · How we verify

NCT03922789

Minimal Important Difference of Walking Test in Subjects With Bronchial Asthma

Completed Last updated 4 August 2020
What this trial tests

trial testing 6 minute walking test in Outcome in 36 participants. Completed in 1 August 2020.

Timeline
16 April 2019
Primary endpoint
1 August 2020
1 August 2020

Quick facts

Lead sponsorMaugeri Foundation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date16 April 2019
Primary completion1 August 2020
Estimated completion1 August 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Maugeri Foundation

Who can join

Adults 45 to 80, any sex, with Outcome or Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Six Minute Walking Test (6MWT) efficiently represents the exercise capacity in subjects with chronic respiratory disease, as asthma. The variation of the walking distance is a parameter used to evaluate the effectiveness of pharmacologic ando non-pharmacologic interventions, as Pulmonary Rehabilitation (PR). However, statistically significant changes in the walking distance do not always represent clinically significant variations.The aim of this prospective study is to determine the Minimal Important Difference (MID) for the 6MWT in subjects affected by asthma, regardless of the severity of the disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of 6 minute walking test

Trials testing the same drug.

Other recruiting trials for Outcome

Currently open trials in the same condition.

Other Maugeri Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing